CHR. HANSEN A/S: Financial statements 2017
CVR: 12516479
Source: annual report 2017, Danish Business Authority
01/09/2016 – 31/08/2017
CHR. HANSEN A/S (CVR 12516479) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 5,530,908,000 and a net result of DKK 1,330,210,000 compared with DKK 1,140,262,000 the year before. That is an increase of 15.1% compared with the year before. The profit margin was 24.1%. Equity in the 2017 report amounted to DKK 2,960,954,000. The solvency ratio was 50.2%.
- Revenue
- DKK 5,530,908,000
- Gross Profit
- DKK 2,842,944,000
- Profit/Loss
- DKK 1,330,210,000
- Equity
- DKK 2,960,954,000
- Total Assets
- DKK 5,895,271,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 5.5B | 2.8B | 1.3B | 3B | - |
| 2016 | 4.8B | 2.4B | 1.1B | 2.6B | - |
| 2015 | 4.3B | 2.2B | 1.1B | 1.4B | - |
| 2014 | 3.7B | 2B | 911.5M | 1.7B | - |
| 2013 | 3.7B | 2B | 892.9M | 1.1B | - |
Official annual report
Keep an eye on CHR. HANSEN A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of May 18, 2017, Winnie Højvang Bügel is registered as adm. dir. of CHR. HANSEN A/S.
As of May 18, 2017, Knud Vindfeldt has stepped down as adm. dir. of CHR. HANSEN A/S.
About CHR. HANSEN A/S
CHR. HANSEN A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 1988. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The company was previously named CHR. HANSEN'S LABORATORIUM DANMARK A/S and A/S PSE NR. 2770. The management consists of Morten Enggaard Rasmussen. The board consists of Rainer Chapour Lehmann (chair), Anders Lund, Helle Rexen and Lisbet Kragelund. The company is owned by NOVOZYMES A/S. The company has 1,747 employees (2026). In 2025, the company reported revenue of DKK 6,820,616,000 and a net result of DKK 2,105,477,000 compared with DKK 1,891,419,000 the year before. Equity in the 2025 report amounted to DKK 11,263,718,000.